211 related articles for article (PubMed ID: 9207866)
41. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
42. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
[TBL] [Abstract][Full Text] [Related]
43. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
44. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
45. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
Mora J; Cheung NK; Juan G; Illei P; Cheung I; Akram M; Chi S; Ladanyi M; Cordon-Cardo C; Gerald WL
Cancer Res; 2001 Sep; 61(18):6892-8. PubMed ID: 11559566
[TBL] [Abstract][Full Text] [Related]
46. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Cheng JM; Hiemstra JL; Schneider SS; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
[TBL] [Abstract][Full Text] [Related]
47. Increased N-myc expression following progressive growth of human neuroblastoma.
Rosen N; Reynolds CP; Thiele CJ; Biedler JL; Israel MA
Cancer Res; 1986 Aug; 46(8):4139-42. PubMed ID: 3731081
[TBL] [Abstract][Full Text] [Related]
48. N-myc gene amplification in neuroblastoma determined by the polymerase chain reaction.
Norris MD; Haber M; Gilbert J; Kavallaris M; Marshall GM; Stewart BW
Prog Clin Biol Res; 1994; 385():27-33. PubMed ID: 7972220
[No Abstract] [Full Text] [Related]
49. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.
Carlsen NL; Mortensen BT; Andersson PK; Larsen JK; Nielsen OH; Tommerup N
Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371
[TBL] [Abstract][Full Text] [Related]
50. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
51. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
Kim MK; Carroll WL
Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
[TBL] [Abstract][Full Text] [Related]
52. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
Sleight BJ; Soukup S; Ballard ET; Parysek LM
Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
[TBL] [Abstract][Full Text] [Related]
53. Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.
Valent A; Venuat AM; Danglot G; Da Silva J; Duarte N; Bernheim A; Bénard J
Med Pediatr Oncol; 2001 Jan; 36(1):100-3. PubMed ID: 11464856
[TBL] [Abstract][Full Text] [Related]
54. [Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma].
Bénard J; Bourhis J; Riou G
Bull Cancer; 1991 Jan; 78(1):91-7. PubMed ID: 2021689
[TBL] [Abstract][Full Text] [Related]
55. Structural features of the amplified N-myc oncogene detected by micrococcal nuclease digestion of neuroblastoma cell nuclei.
Telford DJ; Stewart BW
Biochem Int; 1990 Sep; 21(6):1025-32. PubMed ID: 2080918
[TBL] [Abstract][Full Text] [Related]
56. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors.
Wittrock J; Schweizer P; Girgert R
Anticancer Res; 2002; 22(6C):4205-9. PubMed ID: 12553057
[TBL] [Abstract][Full Text] [Related]
57. [N-myc status of neuroblastoma from bone marrow cells].
Brack T; Finckenstein FG; Kabisch H
Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
[TBL] [Abstract][Full Text] [Related]
58. High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Sharon B; Kennett RH; Rosen ST
Prog Clin Biol Res; 1991; 366():21-7. PubMed ID: 2068139
[No Abstract] [Full Text] [Related]
59. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
60. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]